These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28006693)

  • 1. Clinical implication of frailty assessment in older patients with atrial fibrillation.
    Kim SW; Yoon SJ; Choi JY; Kang MG; Cho Y; Oh IY; Kim CH; Kim KI
    Arch Gerontol Geriatr; 2017; 70():1-7. PubMed ID: 28006693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CHA
    Pundi K; Perino AC; Fan J; Din N; Szummer K; Heidenreich P; Turakhia MP
    Am Heart J; 2023 Jul; 261():85-94. PubMed ID: 37024025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of frailty on anticoagulant prescription and clinical outcomes after 1-year follow-up in hospitalised older patients with atrial fibrillation.
    Gullón A; Formiga F; Díez-Manglano J; Mostaza JM; Cepeda JM; Pose A; Castiella J; Suárez-Fernández C;
    Intern Emerg Med; 2019 Jan; 14(1):59-69. PubMed ID: 30191535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
    Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
    BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.
    Apostolakis S; Lane DA; Buller H; Lip GY
    Thromb Haemost; 2013 Nov; 110(5):1074-9. PubMed ID: 24048467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE
    Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHA
    Choi JY; Sunwoo L; Kim SW; Kim KI; Kim CH
    Sci Rep; 2020 Oct; 10(1):18765. PubMed ID: 33127978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant Therapy in Atrial Fibrillation for Stroke Prevention: Assessment of Agreement Between Clinicians' Decision and CHA2DS2-VASc and HAS-BLED Scores.
    Balaghi-Inalou M; Parsa SA; Gachkar L; Andalib S
    High Blood Press Cardiovasc Prev; 2018 Mar; 25(1):61-64. PubMed ID: 29076078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy.
    Capodanno D; Rossini R; Musumeci G; Lettieri C; Senni M; Valsecchi O; Angiolillo DJ; Lip GY
    Int J Cardiol; 2015 Nov; 199():319-25. PubMed ID: 26241637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHA₂DS₂-VASc scores predict mortality after hospitalization for atrial fibrillation.
    Apiyasawat S; Tangcharoen T; Wisaratapong T; Yamwong S; Wiboonpolprasert S; Sritara P
    Int J Cardiol; 2015 Apr; 185():293-6. PubMed ID: 25819735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation in older inpatients: are there any differences in clinical characteristics and pharmacological treatment between the frail and the non-frail?
    Nguyen TN; Cumming RG; Hilmer SN
    Intern Med J; 2016 Jan; 46(1):86-95. PubMed ID: 26388116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional value of left atrial appendage geometry and hemodynamics when considering anticoagulation strategy in patients with atrial fibrillation with low CHA
    Lee JM; Kim JB; Uhm JS; Pak HN; Lee MH; Joung B
    Heart Rhythm; 2017 Sep; 14(9):1297-1301. PubMed ID: 28559088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA
    Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Marín F; Lip GYH
    Am Heart J; 2018 Mar; 197():27-34. PubMed ID: 29447781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical frailty is independently associated with non-prescription of anticoagulants in older patients with atrial fibrillation.
    Induruwa I; Evans NR; Aziz A; Reddy S; Khadjooi K; Romero-Ortuno R
    Geriatr Gerontol Int; 2017 Nov; 17(11):2178-2183. PubMed ID: 28418196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is CHA
    de Souza MV; de Fátima Dos Santos Teixeira P; Vaisman M; Xavier SS
    Int J Cardiol; 2017 Feb; 228():919-925. PubMed ID: 27912200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
    Golive A; May HT; Bair TL; Jacobs V; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2017 Jul; 120(1):75-82. PubMed ID: 28483209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.